Protective Immunity in Mice Immunized With P. vivax MSP1 19 -Based Formulations and Challenged With P. berghei Expressing Pv MSP1 19 .
Autor: | Dobrescu I; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., de Camargo TM; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Gimenez AM; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Murillo O; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Amorim KNDS; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Marinho CRF; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Soares IS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Boscardin SB; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Bargieri DY; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in immunology [Front Immunol] 2020 Feb 19; Vol. 11, pp. 28. Date of Electronic Publication: 2020 Feb 19 (Print Publication: 2020). |
DOI: | 10.3389/fimmu.2020.00028 |
Abstrakt: | The lack of continuous in vitro cultures has been an obstacle delaying pre-clinical testing of Plasmodium vivax vaccine formulations based on known antigens. In this study, we generated a model to test available formulations based on the P. vivax MSP1 (Copyright © 2020 Dobrescu, de Camargo, Gimenez, Murillo, Amorim, Marinho, Soares, Boscardin and Bargieri.) |
Databáze: | MEDLINE |
Externí odkaz: |